MOREPENLAB.NS

Morepen Laboratories Limited MOREPENLAB.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MOREPENLAB.NS IOLCP.BO IOLCP.NS ALEMBICLTD.NS INDOCO.BO INDOCO.NS SOLARA.NS SOLARA.BO HIKAL.BO HIKAL.NS
6M -10.15 % 40.08 % 40.04 % -3.71 % 18.58 % 17.94 % 13.61 % 13.55 % -43.00 % -43.06 %
YTD -38.83 % 15.10 % 15.19 % -23.42 % -13.50 % -13.67 % -15.66 % -15.60 % -40.02 % -40.10 %
1Y -40.98 % 16.44 % 16.51 % -20.36 % -14.03 % -14.14 % -28.07 % -28.17 % -34.76 % -34.99 %
3Y 78.42 % 31.40 % 31.42 % 52.77 % -14.03 % -14.53 % 55.01 % 55.16 % -26.06 % -25.69 %
5Y 80.75 % -30.06 % -29.99 % 3.67 % 14.13 % 14.70 % -45.26 % -45.50 % 40.91 % 41.19 %
10Y 180.00 % 487.41 % 489.12 % 167.30 % -12.25 % -12.41 % 154.96 % 134.67 % 163.97 % 163.63 %
From the beginning 137.68 % 10 001.28 % 755.51 % 2 423.38 % 443.84 % 445.56 % 154.96 % 134.67 % 464.69 % 2 390.20 %

Dividend

Morepen Laboratories Limited

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

Alembic Limited

Indoco Remedies Limited

Indoco Remedies Limited

Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited

Hikal Limited

Hikal Limited